Skip to main content
. 2022 Oct 1;13(5):1523–1531. doi: 10.14336/AD.2022.0205

Table 3.

Demographic characteristics and patient outcomes of participants not offered treatment with bamlanivimab compared with hospitalization and mortality.

PARTICIPANTS NOT OFFERED TREATMENT
Characteristic Not Offered Treatment Hospitalizations Deaths
n = 46 n = 21 n = 14
Sex n % n % n %
Male 25 54.35 14 66.67 10 71.43
Female 21 45.65 7 33.33 4 28.57
Age
Mean 76.44 78.71 79.64
Median 74.00 77.00 78.00
< 65 11 23.91 2 9.52 2 14.29
65 - 74 10 21.74 6 28.57 3 21.43
75 - 84 11 23.91 6 28.57 4 28.57
85 - 94 8 17.39 4 19.05 3 21.43
≥ 95 6 13.04 3 14.29 2 14.29
Ethnicity
White 39 84.78 18 85.71 11 78.57
African American 6 13.04 3 14.29 3 21.43
Other 1 2.17 0 0 0 0